Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above ...
Oct. 30, 2025 10:17 PM ETResMed Inc. (RMD) Stock, RSMDF StockAI-Generated Earnings Calls Insights ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈